Expression of miR-34a in breast cancer and its molecular mechanism of drug resistance
Zhi-hua LI,Qiu-yun XIONG,Jian-hong TU,Yu GONG,Wei QIU,Er-wei HU
DOI: https://doi.org/10.16073/j.cnki.cjcpt.2017.17.003
2017-01-01
Abstract:OBJECTIVE The objective of this study was to explore the expression of miR-34a in patients with breast cancer and its molecular mechanism of drug resistance in breast cancer.METHODS Totally 113 patients with breast cancer who were diagnosised from Aug.1,2008 to Nov.30,2010 in Third Hospital of Nanchang was choosen.The expression of the miR-34a of the cells and tissues of breast cancer was detected by qRT-PCR.Compared the different expression of the resistant cell and parental cell and analyzed the relationship of the clinicopathologic characteristics and recurrence,metastasis of patients.To analyze the transfection of the miR-34a mimic for MDR-MCF-7,the change of drug resistance index was detected by MTT,cell cycle percentage was detected by flow cytometry,the expression of p53,Bcl-2,TOP-2a,CCND1 and Notch1 was detected by qRT-PCR and Western Blotting.RESULTS The expression of miR-34a of MDR-MCF-7 was 73.8% lower than the MCF-7 of parental cell.After the transfection of the miR 34a mimic for MDR-MCF-7,the IC50 of adriamycin,cyclophosphamide,docetaxel and 5-fluorouracil was lower.The G0/G1 period was retardant,the G2/M period cell number also decreased.miR-34a could lower the expression of the expression of mRNA and protein for Bcl-2,CCND1 and Notch1,the changes of p53 and TOP-2a were not obvious.The expression of miR-34a was related to the expression of mRNA and protein for Bcl-2,CCND1,HER2 and Notch1,but it had nothing to do with menopausal status,histologic type,Staging,ER,PR,p53 and TOP-2a.The expression of miR-34a for patients with recurrent was low than patients without recurrence and metastasis(P<0.01).CONCLUSIONS miR-34a participate in the molecular mechanism of drug resistance in breast cancer,and it can lower the expression of the target gene to inhibit cell drug resistance.The sign of the poor prognosis for breast cancer is the lower expression of miR-34a.